Postnatal Growth Disorder Clinical Trial
— TFO2Official title:
Target Fortification of Breast Milk: The Effect of Different Schedules for Milk Analysis on the Growth and Development of Preterm Infants.
It has been observed that target fortification on different schedules leads to meal to meal
variation. It changes the ratio of protein to energy and the percentage of carbohydrate to
non-protein energy which may, affect growth. In the past, the investigators have analyzed
the outcomes of breast milk composition when target fortification is done with different
analysis schedules. The investigators were able to measure the macronutrient intake for
different milk analysis schedules via a theoretical model and show that the more frequent
schedules reduce the variation of fortified-breast milk, whereas a reduced schedule leads to
a high variation of macronutrients. It was observed that, in all the breast milk samples
measured twice per week, infants achieved on average the recommended macronutrients in line
with current recommendations. Nonetheless, the model only looks at the macronutrient intake
and does not investigates the relationship between macronutrient variation and its effect on
growth.
The aim of the current study is to compare a frequent schedule of measurement of
macronutrient analysis with a reduced schedule of measurement and to study its affect on
growth, protein accretion and metabolic parameter.
Status | Not yet recruiting |
Enrollment | 56 |
Est. completion date | June 2019 |
Est. primary completion date | June 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 29 Weeks |
Eligibility |
Inclusion Criteria: 1. Gestational age < 30 weeks (maternal dates or early fetal ultrasound); 2. Tolerating an enteral intake of =100 mL/kg/d for = 24h; 3. Subject is anticipated to receive the intervention for = 3 consecutive weeks after full enteral feeding (=150 mL/kg/d) has been achieved; 4. Written informed consent has been obtained from the infant's legal representative. 5. Multiple births: Each infant will be included in the study if he/she meets the study criteria, and siblings will be individually randomized to one or other of the treatment arms. 6. Discussion with Most Responsible Physician (MRP) and the staff in order to discuss any potential transfer during the next 7 days. Exclusion Criteria: 1. Gastrointestinal malformation, major congenital anomalies and chromosomal abnormalities; 2. Babies with enterostoma or short gut syndrome; 3. Infants fed more than 25% of mean caloric intake for a consecutive week with formula milk; 4. Fluid restriction <140 mL/kg/d for = 3 consecutive days; 5. Sepsis - all infants with gram-negative sepsis will be removed from the study; 6. Necrotizing enterocolitis, defined by feeding intolerance associated with positive x-ray findings (pneumatosis intestinalis - Bell Stage 2; air in the biliary tract or free air in the peritoneum - Bell Stage 3); 7. Renal disease, defined by symptoms (oliguria, anuria, proteinuria, hematuria) associated with an increased blood urea nitrogen >10 mmol/L and creatinine of 130mmol/L 8. Participation in another clinical trial that may provide an alternative nutritional intervention, which might affect the outcomes of this study. outcomes of this study; 9. Probability of transfer to another neonatal intensive care unit or level II nursery outside the McMaster Children's Hospital, as discussed with the most responsible physician (MRP) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Faculty of Health Science, McMaster Children's Hospital | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster Children's Hospital |
Canada,
Choi A, Fusch G, Rochow N, Fusch C. Target Fortification of Breast Milk: Predicting the Final Osmolality of the Feeds. PLoS One. 2016 Feb 10;11(2):e0148941. doi: 10.1371/journal.pone.0148941. eCollection 2016. — View Citation
Choi A, Fusch G, Rochow N, Sheikh N, Fusch C. Establishment of micromethods for macronutrient contents analysis in breast milk. Matern Child Nutr. 2015 Oct;11(4):761-72. doi: 10.1111/mcn.12053. Epub 2013 Jun 18. — View Citation
Fusch G, Choi A, Rochow N, Fusch C. Quantification of lactose content in human and cow's milk using UPLC-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3759-62. doi: 10.1016/j.jchromb.2011.09.053. Epub 2011 Oct 6. — View Citation
Fusch G, Kwan C, Huang RC, Rochow N, Fusch C. Need of quality control programme when using near-infrared human milk analyzers. Acta Paediatr. 2016 Mar;105(3):324-5. doi: 10.1111/apa.13305. Epub 2016 Jan 19. — View Citation
Fusch G, Mitra S, Rochow N, Fusch C. Target fortification of breast milk: levels of fat, protein or lactose are not related. Acta Paediatr. 2015 Jan;104(1):38-42. doi: 10.1111/apa.12804. Epub 2014 Oct 2. — View Citation
Fusch G, Rochow N, Choi A, Fusch S, Poeschl S, Ubah AO, Lee SY, Raja P, Fusch C. Rapid measurement of macronutrients in breast milk: How reliable are infrared milk analyzers? Clin Nutr. 2015 Jun;34(3):465-76. doi: 10.1016/j.clnu.2014.05.005. Epub 2014 May 17. — View Citation
Kotrri G, Fusch G, Kwan C, Choi D, Choi A, Al Kafi N, Rochow N, Fusch C. Validation of Correction Algorithms for Near-IR Analysis of Human Milk in an Independent Sample Set-Effect of Pasteurization. Nutrients. 2016 Feb 26;8(3):119. doi: 10.3390/nu8030119. — View Citation
Rochow N, Fusch G, Choi A, Chessell L, Elliott L, McDonald K, Kuiper E, Purcha M, Turner S, Chan E, Xia MY, Fusch C. Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants. J Pediatr. 2013 Oct;163(4):1001-7. doi: 10.1016/j.jpeds.2013.04.052. Epub 2013 Jun 12. — View Citation
Rochow N, Fusch G, Zapanta B, Ali A, Barui S, Fusch C. Target fortification of breast milk: how often should milk analysis be done? Nutrients. 2015 Apr 1;7(4):2297-310. doi: 10.3390/nu7042297. — View Citation
Rochow N, Landau-Crangle E, Fusch C. Challenges in breast milk fortification for preterm infants. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):276-84. doi: 10.1097/MCO.0000000000000167. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Growth during first three weeks of intervention | first three weeks during intervention before 36 weeks of gestation | No | |
Secondary | Daily Nutrient intake (kcal, lactose, protein, fat) measured with conventional milk analysis | from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation | No | |
Secondary | Weight Gain | from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation or discharge | No | |
Secondary | Oxidative stress by 8-Oxo-2'-deoxyguanosine metabolites in urine | Measured by mass spectroscopy | from inclusion at postmenstrual age <30 weeks until discharge | No |
Secondary | Protein synthesis analyzed by nitrogen excretion in urine [µmol/mL] | first three weeks during intervention before 36 weeks of gestation | No | |
Secondary | Feeding intolerance questionaire | volume of gastric residuals, color of gastric residuals, vomiting, abdominal girth, abdominal distention | from inclusion at postmenstrual age <30 weeks until discharge | No |
Secondary | Fat mass [g] | Measured with bioelectrical impedance analysis | from inclusion at postmenstrual age <30 weeks until discharge | No |
Secondary | Lean mass [g] | Measured with bioelectrical impedance analysis | from inclusion at postmenstrual age <30 weeks until discharge | No |
Secondary | Head circumference [cm] | Measured by tape | from inclusion at postmenstrual age <30 weeks until discharge | No |
Secondary | Body length [cm] | Measured by length board | from inclusion at postmenstrual age <30 weeks until discharge | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03889197 -
Physiologic Approach to Sodium Supplementation in Premature Infants
|
Phase 4 | |
Completed |
NCT01305642 -
Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study
|
N/A | |
Recruiting |
NCT01609894 -
Individualized Fortification of Breast Milk
|
N/A | |
Completed |
NCT01367015 -
Early Versus Late Initiation of Feeding in Premature Growth Restricted Newborns With Absent or Reversed End Diastolic Flow On Umbilical Artery Doppler (AREDF)
|
N/A |